Style
YieldTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Avalyn Pharmaceuticals Inc(AVLN) | 1,675,830 | $55.2M | 10.37% |
| 2 | Johnson & Johnson(JNJ) | 138,946 | $35.3M | 6.63% |
| 3 | Gilead Sciences Inc(GILD) | 269,309 | $34.0M | 6.39% |
| 4 | Bridgebio Pharma Inc(BBIO) | 455,041 | $33.9M | 6.37% |
| 5 | Syndax Pharmaceuticals Inc(SNDX) | 1,215,698 | $26.6M | 4.99% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 95.47% | 79.38% | -16.09% |
| Unclassified | 4.53% | 20.62% | +16.09% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Definium Therapeutics Inc(DFTX) |
| 562,672 |
| $26.5M |
| 4.97% |
| 7 | Bristol-Myers Squibb Co(BMY) | 412,961 | $23.8M | 4.47% |
| 8 | Parabilis Medicines Inc(PBLS) | 824,043 | $22.6M | 4.24% |
| 9 | Natera Inc(NTRA) | 82,181 | $22.3M | 4.19% |
| 10 | Incyte Corp(INCY) | 191,627 | $21.7M | 4.08% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 35.86% | 29.22% | -6.64% |
| Mid Cap | 38.37% | 24.43% | -13.94% |
| Unclassified | 4.53% | 20.62% | +16.09% |
| Small Cap | 17.35% | 14.2% | -3.15% |
| Mega Cap | 0% | 6.63% | +6.63% |
| Micro Cap | 3.89% | 4.9% | +1.01% |
Quarter-over-quarter position changes